In order to define the role of Gq-mediated signaling in AF in vivo, we used a transgenic mouse line with a tamoxifen-inducible, cardiomyocyte-specific Gαq/Gα11-deficiency (Gq-KO) [14]. This evidence concerns the gene GNAQ and atrial fibrillation.